10-Q: Sleep Number Reports Deep Q3 2025 Losses Amid Sales Decline

Sentiment:

Quarterly Report 5 November 2025 4:21 PM

Sleep Number Corporation reported a significant net loss and revenue decline in Q3 2025, alongside an amended credit agreement to extend maturity and adjust financial covenants.

Capital raiseThe company amended its Credit Agreement on November 4, 2025, extending the maturity date to December 3, 2027.The revolving credit facility was reduced from $485 million to $475 million, with a further reduction to $465 million on July 31, 2026.The amendment adjusted permissible maximum Net Leverage Ratio, minimum Interest Coverage Ratio, and introduced a new quarterly minimum EBITDA covenant test, indicating tighter financial controls and performance requirements.As of September 27, 2025, the company had $579.5 million of borrowings outstanding under its credit facility.The company acknowledged that it has had to seek waivers and amendments to its credit agreement in the past due to industry and business conditions, and may require additional waivers or alternative financing if business performance does not meet expectations, which could be costly or unavailable.

Worse than expectedNet sales decreased significantly by 20% in Q3 2025 and 18% for the nine months, indicating substantial revenue contraction.The company reported a considerable operating loss of $40.3 million in Q3 2025, a sharp reversal from an operating income in the prior year.Net loss widened dramatically to $39.8 million in Q3 2025, reflecting deteriorating profitability.Cash flow from operating activities and free cash flow both turned negative for the nine-month period, signaling a significant deterioration in liquidity and cash generation.The necessity for repeated waivers and amendments to the credit agreement, coupled with the introduction of new, stricter financial covenants, indicates the company is under severe financial pressure and has not met previous expectations.The suspension of 401(k) matching contributions due to business performance is a clear indicator of financial distress.

Summary

Net sales for the three months ended September 27, 2025, decreased 20% to $342.9 million from $426.6 million in the same period last year, driven by lower volume and reduced store count.
Net sales for the nine months ended September 27, 2025, decreased 18% to $1.064 billion from $1.305 billion in the prior year period.
Total Retail comparable sales decreased 19% in Q3 2025 and 17% for the nine months ended September 27, 2025.
The company reported an operating loss of $40.3 million in Q3 2025, a significant decline from an operating income of $8.4 million in Q3 2024.
Net loss for Q3 2025 was $39.8 million, compared to a net loss of $3.1 million in Q3 2024.
Basic and diluted net loss per share for Q3 2025 was $(1.73), compared to $(0.14) in Q3 2024.
Adjusted EBITDA for Q3 2025 was $13 million, down from $28 million in the same period last year.
Gross profit rate decreased to 59.9% in Q3 2025 from 60.8% in Q3 2024, primarily due to higher manufacturing costs and unfavorable logistics.
Restructuring costs totaled $39.2 million in Q3 2025, including $16.1 million for impairment of a strategic product-development partner asset and $19.8 million for impairment of 'go-dark stores'.
Cash used in operating activities for the nine months ended September 27, 2025, was $5 million, a significant shift from $51 million provided in the prior year.
Free cash flow used $17 million for the nine months ended September 27, 2025, compared to $34 million provided in the prior year.
Borrowings under the credit facility stood at $579.5 million as of September 27, 2025.
The company suspended its 401(k) matching contribution effective October 10, 2025, due to current business performance.

Sentiment

Score: 2

Explanation: The company reported substantial declines in sales, gross profit, and a significant net loss, coupled with negative cash flow and increased debt. The need for repeated credit agreement amendments with tighter covenants and the suspension of 401(k) matching highlight severe financial challenges and a precarious financial position, despite a stated 'turnaround strategy'.

Positives

Total Retail average revenue per smart bed unit increased by 4% to $5,995 in Q3 2025, up from $5,771 in Q3 2024.
Lower promotional activity contributed a 0.3 percentage point increase to the gross profit rate in Q3 2025.
A favorable product mix increased the gross profit rate by 0.7 percentage points in Q3 2025.
Sales and marketing expenses decreased by 19% in Q3 2025, including a 32% reduction in media spend.
General and administrative expenses decreased by $1 million in Q3 2025.
Research and development expenses decreased by 20% for the nine months ended September 27, 2025.
Successfully amended the Credit Agreement on November 4, 2025, extending the maturity date and adjusting financial covenants, which provides short-term financial flexibility.

Negatives

Net sales decreased 20% in Q3 2025 and 18% for the nine months, indicating significant revenue contraction.
The company shifted from an operating income of $8.4 million in Q3 2024 to an operating loss of $40.3 million in Q3 2025.
Net loss widened substantially to $39.8 million in Q3 2025 from $3.1 million in Q3 2024.
Gross profit rate declined by 0.9 percentage points in Q3 2025, primarily due to higher manufacturing costs (1.4 ppt deleverage) and unfavorable logistics and home delivery costs (0.5 ppt).
Adjusted EBITDA decreased by over 50% to $13 million in Q3 2025 from $28 million in Q3 2024.
Cash flow from operating activities turned negative, using $5 million for the nine months ended September 27, 2025, compared to providing $51 million in the prior year.
Free cash flow also turned negative, using $17 million for the nine months ended September 27, 2025, compared to providing $34 million in the prior year.
Restructuring costs significantly increased to $39.2 million in Q3 2025 from $2.0 million in Q3 2024, reflecting ongoing operational challenges.
Impairment charges of $16.1 million related to a strategic product-development partner and $19.8 million for 'go-dark stores' indicate asset write-downs.
The suspension of 401(k) matching contributions effective October 10, 2025, signals financial strain impacting employee benefits.
Interest expense increased in Q3 2025 due to higher average debt outstanding.
The company has repeatedly required waivers and amendments to its credit agreement due to non-compliance with financial covenants, indicating persistent financial difficulties.

Risks

Changes in economic conditions and consumer sentiment, and related impacts on discretionary consumer spending.
Elevated and potentially increasing interest rates impacting the cost of servicing the company's indebtedness.
Ability to remain in compliance with the financial covenants in the credit agreement, which depends on the company's ability to execute its business plans; potential need for alternative financing options on unfavorable terms or unavailability.
Availability of attractive and cost-effective consumer credit options.
Ability to achieve cost savings, efficiencies, and other benefits from business restructuring actions and to avoid adverse effects.
Effectiveness and efficiency of the company's marketing strategy and promotions.
Ability to execute Sleep Number's Total Retail distribution strategy.
Ability to compete effectively.
Ability to achieve and maintain high levels of product and service quality.
Ability to improve and expand the product line and execute new product introductions.
Ability to protect the company's technology, trademarks, and brand, and the adequacy of its intellectual property rights.
Dependence on, and ability to maintain working relationships with, key suppliers and third parties, including some that are the only source of supply or services currently used by the company.
Fluctuations in commodity costs or third-party delivery or logistics costs and other inflationary pressures.
Risks inherent in global-sourcing activities, including tariffs, foreign regulation, geo-political turmoil, war, pandemics, labor challenges, foreign currency fluctuations, inflation, climate or other disasters, and resulting supply shortages, and production and delivery delays and disruptions.
Operating with minimal levels of inventory, which may leave the company vulnerable to supply shortages.
Risks of disruption in the operation of any of the company's facilities and operations, including manufacturing, assembly, distribution, logistics, field services, home delivery, headquarters, product development, retail, or customer service operations.
Ability to effectively complete potential future acquisitions and business combinations.
Ability of Sleep Number, and its suppliers and vendors, to attract, retain, and motivate qualified and effective personnel.
Ability to comply with existing and changing government regulations and laws, and to commercialize new products and innovations that meet those existing and changing government regulations and laws.
Ability to identify and withstand cyber threats that could compromise the security of the company's systems or those of third parties upon which it relies and could result in a data breach or business disruption.
Risks associated with advancements in or adoption of artificial intelligence technologies.
Adequacy of the company's and third-party information systems, and costs and disruptions related to upgrading or maintaining these systems.
Volatility of Sleep Number stock, its removal from various stock indices, and the potential negative effects of shareholder activism or of changes in coverage by securities analysts.
Unfavorable tax treatment.
Environmental, social, and governance risks, including increasing scrutiny and evolving regulatory and stakeholder expectations.
Ability to adapt to climate change and readiness for legal or regulatory responses thereto.

Future Outlook

The company introduced a 'turnaround strategy' in November 2025, aiming to reposition the brand, expand customer reach, and reignite growth. It anticipates approximately $3 million in additional restructuring costs through the remainder of 2025. The innovation agenda will prioritize maintaining and improving core technologies, introducing advancements, and reducing product costs. The company will continue to monitor its real estate footprint, which may lead to further impairment charges.

Management Comments

The bedding industry has been in a sector level recession for three years with mattress industry unit volumes returning to an estimated 24 million units in 2024, the lowest level since 2015.
Consumer sentiment remains well below historical averages, and high interest rates are putting ongoing pressure on the housing market. Consumers continue to scrutinize spending, with inflation and other factors weighing on their purchasing power.
In November 2025, the Company introduced its turnaround strategy, a focused, company-wide effort to reposition the brand, expand reach to new customer groups, and reignite growth.
Moving forward, the Company's innovation agenda will focus on maintaining and improving the Company's core technologies and introducing additional advancements, while driving costs out of the product.
While the Company's consumer innovation pipeline remains robust, it is re-prioritizing R&D resources in this highly constrained environment.
Effective October 10, 2025, the Company suspended the 401(k) matching contribution due to current business performance.

Industry Context

The bedding industry has been experiencing a 'sector level recession' for three years, with mattress industry unit volumes in 2024 estimated at 24 million units, marking the lowest level since 2015. This challenging environment is exacerbated by low consumer sentiment, high interest rates impacting the housing market, and inflationary pressures causing consumers to scrutinize discretionary spending.

Comparison to Industry Standards

The filing indicates that the broader mattress industry is in a 'sector level recession' with unit volumes at their lowest since 2015, suggesting that the company's declining sales are occurring within a challenging market context. However, the filing does not provide specific comparable companies, projects, or results to benchmark Sleep Number's performance against industry peers.

Management Changes

Role	Previous Person	New Person	Effective Date	Reason
Chief Executive Officer	NA	Linda Findley	2025-11-05	Implied current appointment, following 'CEO search costs' mentioned earlier in the year.
Interim Chief Financial Officer	NA	Robert P. Ryder	2025-11-05	Interim appointment, as indicated by signing as 'Interim Chief Financial Officer'.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Credit Agreement Amendment	The Amended and Restated Credit and Security Agreement, dated November 4, 2025, extends the maturity date to December 3, 2027, reduces the revolving credit facility, and adjusts several financial covenants including Net Leverage Ratio, Interest Coverage Ratio, Liquidity, and introduces a new quarterly minimum EBITDA covenant test.	2025-11-04	Provides necessary financial flexibility and extends debt maturity, but imposes stricter financial performance requirements and increased reporting obligations, reflecting a more constrained operating environment.

Legal Proceedings

A purported class action complaint was served on January 14, 2025, in the United States District Court for the Central District of California, alleging that Sleep Number's beds are perpetually on sale in violation of California law. The court granted Sleep Number's motion to dismiss on April 8, 2025, based on the first-to-file doctrine.
A separate purported class action complaint was served on September 27, 2024, in the United States District Court for the Eastern District of California, also alleging that Sleep Number's beds are perpetually on sale in violation of California law. The plaintiff seeks injunctive relief, damages, and attorneys' fees.

Stakeholder Impact

Shareholders: Negative impact due to significant financial losses, declining revenue, negative cash flow, and increased debt, likely leading to continued share price volatility and erosion of shareholder value.
Employees: Negative impact due to restructuring activities, implied layoffs (from severance costs), and the suspension of 401(k) matching contributions, potentially affecting morale and retention.
Creditors: Increased risk profile due to the company's repeated non-compliance with financial covenants, necessitating credit agreement amendments, although the amendments provide a framework for continued debt servicing.
Customers: Potential impact from 'go-dark stores' and a reprioritization of R&D resources, which could affect product availability or future innovation.

Next Steps

Implement the 'turnaround strategy' to reposition the brand, expand customer reach, and reignite growth.
Incur approximately $3 million of additional restructuring costs through the remainder of 2025.
Focus the innovation agenda on maintaining and improving core technologies, introducing additional advancements, and driving costs out of products.
Continue to monitor the real estate footprint, which may lead to additional impairment charges in future periods.
Comply with the adjusted financial covenants (Net Leverage Ratio, Interest Coverage Ratio, Liquidity, and new minimum EBITDA covenant) under the amended credit agreement.

Key Dates

Date	Description
2023-09-28	End of three and nine months period for prior year comparison.
2023-12-30	Balance at beginning of year for Shareholders Deficit table (prior year).
2024-03-30	Balance at March 30, 2024 for Shareholders Deficit table (prior year).
2024-06-29	Balance at June 29, 2024 for Shareholders Deficit table (prior year).
2024-09-27	Purported class action complaint served in the Eastern District of California.
2024-12-15	Effective date for ASU 2023-09, 'Income Taxes (Topic 740): Improvements in Income Tax Disclosures'.
2024-12-28	Fiscal year end for 2024; Balance at beginning of year for Shareholders Deficit table (current year).
2025-01-14	Purported class action complaint served in the Central District of California.
2025-03-03	Eleventh Amendment Effective Date for the Credit Agreement.
2025-03-29	Balance at March 29, 2025 for Shareholders Deficit table (current year).
2025-04-08	Court granted Sleep Number's motion to transfer or dismiss the class action complaint in the Central District of California.
2025-06-28	Balance at June 28, 2025 for Shareholders Deficit table (current year).
2025-07-04	The One Big Beautiful Bill Act (OBBBA) was enacted into law.
2025-09-27	End of current three and nine months period.
2025-10-10	Company suspended 401(k) matching contribution due to current business performance.
2025-11-04	Twelfth Amendment to Amended and Restated Credit and Security Agreement effective date.
2025-11-05	Filing date of the 10-Q report.
2026-01-03	Quarterly reporting period end for which Net Leverage Ratio covenant is 4.50 to 1.00 and Interest Coverage Ratio is 2.10 to 1.00.
2026-01-04	Effective date for ASU 2025-05, 'Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets'.
2026-04-04	Quarterly reporting period end for which Net Leverage Ratio covenant is 4.75 to 1.00, Interest Coverage Ratio is 2.10 to 1.00, and a new quarterly minimum EBITDA covenant test begins.
2026-07-04	Quarterly reporting period end for which Net Leverage Ratio covenant is 4.80 to 1.00 and Interest Coverage Ratio is 1.80 to 1.00.
2026-07-31	Revolving credit facility decreases from $475 million to $465 million.
2026-09-30	Liquidity financial covenant requires no lower than $30 million until this date.
2026-10-03	Quarterly reporting period end for which Interest Coverage Ratio is 2.10 to 1.00.
2027-01-01	Applicable Margin for Term SOFR Loans becomes 4.25% and Applicable Commitment Fee Rate becomes 0.75% (if 100% Extending Lender Consent obtained).
2027-03-31	Amortization of outstanding term loans increases by an additional $1,250,000 (for an aggregate scheduled principal payment of $3,750,000).
2027-12-03	Extended maturity date of the Credit Agreement.
2028-01-01	Interim periods beginning in 2028 are effective for ASU 2024-03, 'Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosures'.

Recommendation

sell

The company is experiencing severe financial distress, evidenced by substantial net losses, significant revenue decline, negative cash flow from operations, and a deteriorating Adjusted Return on Invested Capital. The necessity for repeated amendments to its credit agreement, coupled with the suspension of employee 401(k) matching contributions, underscores a precarious financial position and operational challenges. While a 'turnaround strategy' is mentioned, the current financial performance and the tight new debt covenants suggest a high degree of risk and uncertainty. Investors should consider selling due to the significant downside risk and lack of clear positive catalysts in the near term.

Keywords

Sleep Number, SNBR, smart bed, bedding industry, Q3 2025 results, net loss, revenue decline, credit agreement amendment, restructuring costs, financial covenants, liquidity, consumer spending, economic recession, corporate governance, retail performance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.